Genomic Diagnosis and Treatment of Complex Vascular Birthmarks and Overgrowth Syndromes

Conclusions

• Extensive capillary malformations in a newborn are often a clue to an underlying mosaic overgrowth syndrome rather than an isolated skin finding.
• The clinical pattern, distribution, and morphology of a vascular birthmark help narrow the likely genetic diagnosis and organ systems that may be involved.
• Diffuse or unusual capillary malformations should prompt a careful search for associated brain, eye, limb, skeletal, lymphatic, and visceral abnormalities.
• Reticulated and geographic vascular patterns are especially suggestive of PIK3CA-related overgrowth spectrum and related syndromic disorders.
• Mosaic vascular disorders are heterogeneous and overlap substantially, so rigid clinical categories are less useful than a case-by-case evaluation.
• Genomic advances have transformed the classification of vascular birthmarks and are now central to diagnosis and management.
• Many causative variants are somatic and may be missed on routine blood testing, so affected tissue and deep sequencing are often required.
• The same pathway mutations can produce different phenotypes depending on timing, tissue distribution, and mutation burden, and variant allele fraction does not reliably predict severity.
• A detailed physical exam focused on head size, limb asymmetry, digits, and feet can reveal key clues to syndromic overgrowth.
• In complex cases, imaging and laboratory evaluation should be integrated with the skin findings to assess for brain asymmetry, venous anomalies, lymphatic leakage, and coagulopathy.
• Patients with PIK3CA-related overgrowth spectrum can develop serious neonatal complications such as hypoglycemia, lymphatic effusions, and localized intravascular coagulopathy.
• Current evidence suggests that routine cancer screening, including universal Wilms tumor surveillance, is not clearly justified for most PROS patients.
• Targeted therapies such as sirolimus and other pathway-directed agents can improve symptoms, bleeding, clotting, and quality of life in selected patients.
• Overall, the best care for these disorders comes from combining dermatologic pattern recognition with genomics, imaging, and multidisciplinary follow-up.